$1.41
-0.02-1.12%
At Close: -
15 minutes delayed
Agile Therapeutics
AGRXOTCQB
Agile Therapeutics (AGRX) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAgile Therapeutics (OTC:AGRX) Stock Quotes, Forecast and News Summary
Agile Therapeutics Stock (OTC: AGRX) stock price, news, charts, stock research, profile.
| Open | $1.40 |
| Close | $1.41 |
| Volume / Avg. | 393.94K / 150.74K |
| Day Range | 1.38 - 1.42 |
| 52 Wk Range | 0.20 - 3.40 |
| Market Cap | $9.69M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | OTC |
| RSI | 0 |
| Short Interest | - |
| Days to Cover | 3.45 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Agile Therapeutics Inc
Sector
Health Care
Industry
Pharmaceuticals
Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. I...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Agile Therapeutics (AGRX) stock?
You can purchase shares of Agile Therapeutics (OTCQB:AGRX) through any online brokerage.
Who are Agile Therapeutics (AGRX) competitors?
There are no as such competitors for Agile Therapeutics.
What is the target price for Agile Therapeutics (AGRX) stock?
There is no analysis for Agile Therapeutics.
What is the forecast for Agile Therapeutics (AGRX) stock?
Agile Therapeutics has a consensus price target of $4.25.
Current stock price for Agile Therapeutics (AGRX)?
The stock price for Agile Therapeutics (OTCQB: AGRX) is $1.414 last updated June 28, 2024 at 3:54 PM EDT.
Does Agile Therapeutics (AGRX) pay a dividend?
There are no upcoming dividends for Agile Therapeutics.
When is Agile Therapeutics (OTCQB:AGRX) reporting earnings?
Agile Therapeutics’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
Is Agile Therapeutics (AGRX) going to split?
There is no upcoming split for Agile Therapeutics.
What sector and industry does Agile Therapeutics (AGRX) operate in?
Agile Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQB.